Cingulate submitted its New Drug Application (NDA) for CTx-1301 to the FDA, targeting the ADHD market, with an NDA acceptance decision expected in late 2025. Operating expenses increased for the three ...

A case study published in Frontiers in Psychiatry details how a 28-year-old man with Tourette syndrome (TS) and ADHD ...

Jodie Stauffer has a different perspective. The financial services veteran has built a successful practice serving the unique ...

I recently asked myself if I'll still have a healthy brain as I get older. I hold a professorship at a neurology department. Nevertheless, it is difficult for me to judge if a particular brain, ...

Alora Pharmaceuticals, LLC, the parent company of Vertical Pharmaceuticals, LLC, a leading pharmaceutical company committed to advancing access to high-quality therapies, announces the publication of ...

What Happened: Hudson's decision to sell 7,457 shares of Supernus Pharmaceuticals was revealed in a Form 4 filing with the U.S. Securities and Exchange Commission on Monday. The total value of the ...

A nationwide study from Finland provides evidence that adults diagnosed with attention-deficit hyperactivity disorder (ADHD) ...

UC Davis Health researchers found that many autistic children also meet criteria for ADHD, emphasizing the importance of ...